Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET

Journal of Nuclear Medicine

Volumn 39, Issue 6, 1998, Pages 1002-1007

  Fukunaga, Toru ^a   Okazumi, Shinichi ^a   Koide, Yoshio ^a   Isono, Kaichi ^a   Imazeki, Keiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Fluorine 18 fluorodeoxyglucose; PET; Prognosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEXOKINASE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CLINICAL ARTICLE; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SYNTHESIS;

ADULT; AGED; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031811481     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sharma RM, Sharma C, Donnelly AJ, et al. Glucose-ATP phospho-transferases during hepatocarcinogenesis. Cancer Res 1965;25:196-199.
2. Knox WE, Jamdar SC, Davis PA, et al. Hexokinase, differentiation and growth rates of transplanted rat tumors. Cancer Res 1970;30:2240-2244.
3. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1987;22:360-371.
4. 18F]fluoro-D-glucose in liver metastasis from colon cancer. J Nucl Med 1982;23: 1133-1137.
5. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-1932.
6. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33:333-339.
7. Yasuda S, Raja S, Hubner KF. Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case. Surg Today 1995;25:261-264.
8. Woodard HQ, Bigler RE, Freed B, et al. Expression of tissue isotope distribution. J Nucl Med 1975;16:958-959.
9. 18F]2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
10. Monakhov NK, Neistadt EL, Shavlovskii MM, et al. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978;61:27-34.
11. 18F-FDG-PET: differential diagnosis of malignancy from benignity. Jpn J Nucl Med 1992;29:687-690.
12. Yoshioka T, Takahashi H, Oikawa H, Kanemaru R. Experimental study on the effectiveness of PET tumor images for cancer diagnosis. Jpn J Cancer Chemother 1994;21:369-373.
13. Hermanek P, Sobin LH. UICC: TNM classfication of malignant tumours, 4th revised ed. Berlin Heidelberg: Springer-Verlag; 1987.
14. Japanese Society for Esophageal Disease. Guidelines for the clinical and pathologic studies on carcinoma of esophagus. 8th ed. Tokyo: Kanehara; 1992.
15. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
16. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
17. Weber G, Cantero A. Glucose-6-phosphatase activity in normal, precancerous and neoplastic tissues. Cancer Res 1955;15:105-108.
18. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-1161.
19. 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997;168: 417-424.
20. Weber G. In: The molecular correlation concept: studies on the metabolic pattern of hepatomas. Tokyo: Maruzen Co.; 1966: 151-178.
21. 18F]FDG. J Compt Assist Tomogr 1990;14:960-962.
22. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluorine-18-fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-1352.
23. Di Chiro G, Hatazawa J, Katz DA, et al. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 1987;164:521-526.
24. 18F-fluorodeoxyglucose. J Jpn Surg Soc 1994;95:317-325.
25. Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655-1660.